GelTex Pharmaceuticals develops and markets non-absorbed polymer drugs.
GelTex Pharmaceuticals develops and markets non-absorbed polymer drugs that bind and eliminate targeted substances within the gastrointestinal tract. It also develops small-molecule pharmaceuticals consisting of novel polyamine analogues and metal chelators. Its focus areas include hyperphosphatemia, hypercholesterolemia, cancer, iron overload, and infectious diseases.GelTex Pharmaceutics is based in Waltham Massachusetts.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 9, 1993 | Series Unknown | $6.80M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Norwest Venture Partners | — | Series Unknown |
Biotechnology Investments | — | Series Unknown |